Global miRNA Tools and Services Market Size, Share, and COVID-19 Impact Analysis, By Product & Services (Research Tools and Services), By Technology (Extraction Tools, qRT-PCR, NGS, Microarray, Functional Analysis Tools, and Others), By End User (Research & Academic Institutes, IVD, Pharma & Biotech Companies, and CROs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global MiRNA Tools and Services Market Insights Forecasts to 2035

• The Global MiRNA Tools and Services Market Size Was Estimated at USD 454.9 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 18.16% from 2025 to 2035
• The Worldwide MiRNA Tools and Services Market Size is Expected to Reach USD 2850.5 Million by 2035
• Asia Pacific is Expected to Grow the Fastest During the Forecast Period.

The Global miRNA Tools and Services Market Size was worth around USD 454.9 Million in 2024 and is Predicted to Grow to around USD 2850.5 Million by 2035 with a Compound Annual Growth Rate (CAGR) of 18.16% from 2025 to 2035. The growing prevalence of cancer, funding in gene manipulation therapies, and research & innovative drug development methodologies are driving the miRNA tools and services market globally.

Market Overview

The miRNA tools and services market refers to the industry of products and services facilitating the analysis, profiling, and quantification of miRNA, which are small, non-coding RNA molecules crucial for gene regulation. miRNA tools and services help researchers extract, quantify, and analyze miRNAs, ultimately providing insights into their function in diverse biological processes and diseases. It comprises bioinformatics software and databases for predicting and analyzing miRNA target genes, and unraveling their functions across a diverse range of biological processes. Incorporation of miRNA tools with multi-omics approaches is creating a new market growth opportunity for miRNA tools and services. Further, the development of user-friendly, clinically validated miRNA tools that can be seamlessly integrated into diagnostic and prognostic workflows is anticipated to escalate the market growth opportunity.

Report Coverage

This research report categorizes the miRNA tools and services market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the miRNA tools and services market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the miRNA tools and services market.

Driving Factors

The growing prevalence of cancer is responsible for driving the market demand for miRNA tools and services, as these are crucial regulators in cancer, impacting tumorigenesis, progression, and resistance to therapy. According to the WHO, 20 million new cancer cases and 9.7 million deaths were estimated in the year 2022. Increasing funding in gene manipulation therapies, with factors such as advancements in gene editing technologies, prevalence of genetic disorders, and demand for personalized medicine, is contributing to propel the market growth. The growing research and innovative drug development methodologies that are critical for advancing healthcare and improving patient outcomes are promoting the market growth.

Restraining Factors

The limited standardization and complex data analysis are significantly restraining the miRNA tools and services market. Further, the shortage of skilled personnel and regulatory hurdles are limiting the market growth.

Market Segmentation

The miRNA tools and services market share is classified into product & services, technology, and end user.

• The research tools segment dominated the market with the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product & services, the miRNA tools and services market is divided into research tools and services. Among these, the research tools segment dominated the market with the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period. It encompasses a suite of bioinformatics software, databases, and experimental technologies that are designed for identifying, profiling, and functional analysis of miRNAs.

• The qRT-PCR segment accounted for a significant revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the technology, the miRNA tools and services market is divided into extraction tools, qRT-PCR, NGS, microarray, functional analysis tools, and others. Among these, the qRT-PCR segment accounted for a significant revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. qRT-PCR is a real-time quantitative reverse transcription PCR that enables reliable detection and measurement of products generated using each cycle of the PCR process. The trend towards high sensitivity and specificity that allows researchers to detect accurate low-abundance miRNAs is driving the market growth in the qRT-PCR segment.

• The research & academic institutes segment accounted for a significant revenue share in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.

Based on the end user, the miRNA tools and services market is divided into research & academic institutes, IVD, pharma & biotech companies, and CROs. Among these, the research & academic institutes segment accounted for a significant revenue share in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. In research & academic institutes, miRNA tools and services aid in understanding gene regulation and the development of new diagnostic and therapeutic approaches. An increasing focus on miRNA research for understanding gene regulation is contributing to enhancing the market growth in the research & academic institutes segment.

Regional Segment Analysis of the MiRNA Tools and Services Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the miRNA tools and services market over the predicted timeframe.

North America is anticipated to hold the largest share of the miRNA tools and services market over the predicted timeframe. The presence of robust research infrastructure, substantial investments in genomics, and collaborations among research institutes and biotech companies are driving the miRNA tools and services market. Further, the growing prevalence of cancer, along with an increase in the geriatric population, is anticipated to drive the market demand.  

Asia Pacific is expected to grow at a rapid CAGR in the miRNA tools and services market during the forecast period. A strong investment in biotechnology firms, providing miRNA treatment that boosts the flow of miRNA research, is significantly contributing to driving the market of miRNA tools and services. Further, the growing prevalence of chronic diseases, along with an increase in researchers exploring the role of miRNAs in the development, treatment, and diagnosis of cancer, is expected to drive the market.

Europe is anticipated to grow at a significant CAGR in the miRNA tools and services market during the projected timeframe. Increasing investments in biotechnology and pharmaceutical industries are contributing significantly to bolstering the market for miRNA tools and services. In addition, an increasing number of approved patents of miRNA biomarkers, as well as infrastructure development for genomics, proteomics, and oncology research, is expected to propel the miRNA tools and services market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the miRNA tools and services market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Thermo Fisher Scientific
• Agilent Technologies
• Qiagen
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• PerkinElmer, Inc.
• Takara Bio Inc.
• New England Biolabs
• NanoString Technologies, Inc.
• Exiqon (Qiagen)
• GeneCopoeia, Inc.
• Promega Corporation
• Roche Diagnostics
• Abcam plc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In June 2024, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced the launch of the ddSECTM Single-cell 3RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the miRNA tools and services market based on the below-mentioned segments: 

Global miRNA Tools and Services Market, By Product & Services

• Research Tools
• Services

Global MiRNA Tools and Services Market, By Technology

• Extraction Tools
• qRT-PCR
• NGS
• Microarray
• Functional Analysis Tools
• Others

Global MiRNA Tools and Services Market, By End User

• Research & Academic Institutes
• IVD
• Pharma & Biotech Companies
• CROs

Global MiRNA Tools and Services Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa